Vertex Pharmaceuticals Inc (VRTX)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 9,803,200 9,596,700 9,444,700 9,144,300 8,863,500 8,628,770 8,277,080 7,873,370 7,499,400 7,066,960 6,622,470 6,355,190 6,147,530 5,935,020 5,347,582 4,763,428 4,106,025 3,577,111 3,416,521 3,232,116
Receivables US$ in thousands 1,563,400 1,538,700 1,556,200 1,547,800 1,442,200 1,385,200 1,332,900 1,292,800 1,136,800 1,100,370 929,142 977,551 885,352 791,917 791,768 845,269 633,518 443,315 464,900 438,297
Receivables turnover 6.27 6.24 6.07 5.91 6.15 6.23 6.21 6.09 6.60 6.42 7.13 6.50 6.94 7.49 6.75 5.64 6.48 8.07 7.35 7.37

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $9,803,200K ÷ $1,563,400K
= 6.27

The receivables turnover ratio measures how effectively Vertex Pharmaceuticals, Inc. collects payments from its customers. A higher ratio indicates that the company is collecting payments more quickly, which is generally viewed as positive.

Analyzing the data provided, we observe that Vertex's receivables turnover ratio has varied over the past eight quarters. In Q4 2023, the ratio was 6.31, slightly higher than the previous quarter at 6.27. This suggests that Vertex improved its efficiency in collecting receivables during this period.

Comparing the latest ratio to the same period last year, Q4 2022 had a lower ratio of 6.19. However, it is worth noting that the ratio has generally been consistently above 6 over the past year, indicating that Vertex has been managing its accounts receivable efficiently.

Overall, the trend in Vertex's receivables turnover ratio shows that the company has been effectively collecting payments from its customers, maintaining a healthy turnover rate above 6 for the past eight quarters. This suggests strong management of accounts receivable and liquidity, which is a positive indicator for the company's financial health.


Peer comparison

Dec 31, 2023


See also:

Vertex Pharmaceuticals Inc Receivables Turnover (Quarterly Data)